Armitage James O - 19 Mar 2021 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ James Armitage
Issuer symbol
CRDF
Transactions as of
19 Mar 2021
Net transactions value
+$43,271
Form type
4
Filing time
27 May 2021, 17:14:06 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $43,271 +4,000 +38% $10.82* 14,490 19 Mar 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.795 to $10.82, inclusive.